• Tidak ada hasil yang ditemukan

name of health care facility, city, state and country

N/A
N/A
Protected

Academic year: 2024

Membagikan "name of health care facility, city, state and country"

Copied!
6
0
0

Teks penuh

(1)

1. Please state: name of health care facility, city, state and country

 

2. Please state your role in your OPAT center

3. Approximately how many OPAT patients do you treat per year?

4. Does your OPAT center treat patients with a history of intravenous drug use (IVDU)?

 

Doctor in charge of OPAT  n

m l k j

Doctor  n m l k j

Nurse in charge of OPAT  n

m l k j

Nurse  n m l k j

Other  n m l k j

<100  n m l k j

100­300  n

m l k j

300­500  n

m l k j

>500  n m l k j

we do not inquire about IVDU in our patients  n

m l k j

we are not referred any IVDU patients  n

m l k j

yes, but only if the patients are not currently using  n

m l k j

yes, if we believe it is safe  n

m l k j

never  n m l k j

we used to but have now stopped (please specify reason) 

  n

m l k j

(2)

1. Why are IVDU patients excluded in your OPAT center? (select all that apply)

2. What factors do you think could help change the above policy restriction? (select all that apply)

3. Which statement best describes your routine practice for IVDU patients?

 

national policy  g

f e d c

health care institution policy  g

f e d c

OPAT center policy  g

f e d c

personal approach  g

f e d c

published safety data on treating IVDU patients in OPAT  g

f e d c

improved support from institutional legal departments  g

f e d c

improved social support systems for these patients (including drug counseling) during OPAT  g

f e d c

effective mechanisms to prevent PICC abuse  g

f e d c

no factors could change the policy  g

f e d c

Other (please specify) 

  g

f e d c

I aim to complete entire duration of intravenous therapy while patients are in hospital  n

m l k j

I transfer patients to a step down institution for the remainder of their intravenous antibiotics  n

m l k j

I aim for earlier switch to oral antibiotics  n

m l k j

(3)

1. Approximately what percentage of your OPAT patients are current or recent IVDUs?

2. Do you allow PICCs to be used in current or recent IVDU patients?

3. What ROUTINE measures are used in your centre when treating current or recent IVDU patients? (select all that apply)

4. What is your policy with respect to patients suspected of IVDU during OPAT?

5. What outcomes data (if any) do you record in IVDU patients (select all that apply)?

<1  n m l k j

1­5  n m l k j

5­10  n m l k j

>10  n m l k j

yes, most of the time  n

m l k j

yes, but we use alternatives as much as possible eg intramuscular route, removal of needle after each infusion  n

m l k j

never  n m l k j

verbal counseling on compliance requirements and risks of PICC abuse  g

f e d c

signed contract detailing compliance requirements and risks of PICC abuse  g

f e d c

substance abuse counseling services  g

f e d c

tamper proof seals/dressings over PICCs  g

f e d c

urine drug screens  g

f e d c

policy of no home infusions (ie patient returns to OPAT center daily for treatment)  g

f e d c

transfer from hospital to step down facility for completion of OPAT  g

f e d c

other (please specify) 

  g

f e d c

IVDU is not tolerated  n

m l k j

IVDU is tolerated as long as PICC is not abused  n

m l k j

PICC abuse tolerated as long as patient compliant with attendence  n

m l k j

failure rates and the reason  g

f e d c

readmission rates  g

f e d c

PICC abuse  g

f e d c

ongoing drug abuse  g

f e d c

no outcome data recorded  g

f e d c

(4)

6. Approximately what percentage of current or recent IVDU patients fail to follow up with the OPAT treatment plan at your center?

7. What legal concerns (if any) do you have with treating current or recent IVDU patients in OPAT? (select all that apply)

8. What other concerns (if any) do you have with treating current or recent IVDU patients in your OPAT? (select all that apply)

9. Which statement best reflects your view on the treatment of current or recent IVDU patients in OPAT?

<5  n m l k j

5­10  n m l k j

10­20  n m l k j

>20  n m l k j

inadequate safety and efficacy data  g

f e d c

inadequate follow up and support systems  g

f e d c

as a health practitioner you are facilitating drug abuse, an illegal activity  g

f e d c

difficulties in proving that the patient is sufficiently informed and consented  g

f e d c

no specific legal concerns  g

f e d c

other (please specify) 

  g

f e d c

concerns for staff safety  g

f e d c

inadequate formal drug counseling & support  g

f e d c

extra demands on nursing time  g

f e d c

nil  g f e d c

other (please specify) 

  g

f e d c

it is mostly safe and successful  n

m l k j

it is less safe and successful than in non­IVDU patients however the benefits outweigh the risks  n

m l k j

it is not safe and the whole system concerns me  n

m l k j

(5)

11. When considering a patient with a history of illicit drug abuse NOT via the intravenous route...

 

0  n m l k j

1­2  n m l k j

3­5  n m l k j

>5  n m l k j

If >5, please specify approx. number 

you feel more comfortable treating and allowing PICC access  n

m l k j

you manage them the same as the intravenous abusers  n

m l k j

you would be more concerned  n

m l k j

(6)

1. Please comment on any futher aspects on this issue that we may have missed in the survey.

  END OF SURVEY, THANK YOU FOR YOUR PARTICIPATION. 

55 66

Referensi

Dokumen terkait